You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Momelotinib

Showing 1 - 16 of 16
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Myelofibrosis Trial (Momelotinib)

Available
  • Myelofibrosis
  • Momelotinib
  • (no location specified)
Oct 12, 2022

Primary Myelofibrosis, Post-Polycythemia Vera Myelofibrosis, Post-Essential Thrombocythemia Myelofibrosis Trial in Worldwide

Completed
Has Results
  • Primary Myelofibrosis
  • +4 more
  • Momelotinib
  • Scottsdale, Arizona
  • +21 more
Jan 18, 2021

Primary Myelofibrosis (PMF), Post-polycythemia Vera (Post-PV) Myelofibrosis, Postessential Thrombocythemia (Post-ET)

Completed
Has Results
  • Primary Myelofibrosis (PMF)
  • +2 more
  • Phoenix, Arizona
  • +12 more
Jan 12, 2021

Polycythemia Vera, Essential Thrombocythemia Trial in Worldwide (Momelotinib)

Terminated
  • Polycythemia Vera
  • Essential Thrombocythemia
  • Momelotinib
  • Scottsdale, Arizona
  • +14 more
Apr 14, 2020

Primary Myelofibrosis, Post-polycythemia Vera Myelofibrosis, Post-essential Thrombocythemia Myelofibrosis Trial in Worldwide

Active, not recruiting
  • Primary Myelofibrosis
  • +2 more
  • Momelotinib
  • +3 more
  • Phoenix, Arizona
  • +166 more
Jan 27, 2022

Primary Myelofibrosis (PMF), Post-polycythemia Vera (Post-PV), Post-essential Thrombocythemia Myelofibrosis (Post-ET MF) Trial

Completed
  • Primary Myelofibrosis (PMF)
  • +2 more
  • Momelotinib
  • Best Available Therapy (BAT)
  • Los Angeles, California
  • +47 more
Apr 1, 2020

Primary Myelofibrosis, Post-Polycythemia Vera Myelofibrosis, Post-Essential Thrombocythemia Myelofibrosis Trial in Worldwide

Completed
  • Primary Myelofibrosis
  • +2 more
  • Momelotinib
  • +3 more
  • Phoenix, Arizona
  • +113 more
Apr 13, 2020

Metastatic Pancreatic Ductal Adenocarcinoma Trial in United States (Momelotinib, Placebo to match momelotinib, Nab-paclitaxel)

Terminated
Has Results
  • Metastatic Pancreatic Ductal Adenocarcinoma
  • Momelotinib
  • +3 more
  • Los Angeles, California
  • +3 more
Jan 31, 2019

EGFR Mutated EGFR TKI Naive Metastatic NSCLC Trial in Duarte, Palo Alto, Whittier (Momelotinib (MMB), Erlotinib)

Terminated
  • EGFR Mutated EGFR TKI Naive Metastatic NSCLC
  • Duarte, California
  • +2 more
Jan 30, 2019

Relapsed/Refractory Metastatic Pancreatic Ductal Adenocarcinoma Trial in United States (Momelotinib (MMB), Capecitabine,

Terminated
  • Relapsed/Refractory Metastatic Pancreatic Ductal Adenocarcinoma
  • Momelotinib (MMB)
  • +2 more
  • Scottsdale, Arizona
  • +3 more
Jan 30, 2019

Relapsed Metastatic KRAS-Mutated NSCLC Trial in United States (Momelotinib (MMB), Trametinib)

Terminated
  • Relapsed Metastatic KRAS-Mutated Non-Small Cell Lung Cancer
  • Duarte, California
  • +4 more
Jan 30, 2019

Primary Myelofibrosis, Post-Polycythemia Vera, Post-Essential Thrombocythemia Myelofibrosis Trial in Canada, United States

Completed
  • Primary Myelofibrosis
  • +2 more
  • Momelotinib
  • Scottsdale, Arizona
  • +5 more
Jan 31, 2019

Primary Myelofibrosis, Post-Polycythemia Vera Myelofibrosis, Post-Essential Thrombocythemia Myelofibrosis Trial in Australia,

Completed
  • Primary Myelofibrosis
  • +2 more
  • Momelotinib
  • Stanford, California
  • +5 more
Jan 31, 2019

Primary Myelofibrosis, Post-Polycythemia Vera Myelofibrosis, Post-Essential Thrombocythemia Myelofibrosis Trial in Australia,

Completed
  • Primary Myelofibrosis
  • +2 more
  • Stanford, California
  • +5 more
Jan 30, 2019

Cancer Target Therapy Efficacy

Active, not recruiting
  • Cancer
  • RNA sequencing
  • +5 more
  • Walnut, California
  • +6 more
Sep 13, 2021

Primary Myelofibrosis, Post-polycythemia Vera Myelofibrosis, Post-essential Thrombocythemia Myelofibrosis Trial in Worldwide

Recruiting
  • Primary Myelofibrosis
  • +2 more
  • Birmingham, Alabama
  • +151 more
Aug 22, 2022